PPA
TNDM icon

Parametric Portfolio Associates’s Tandem Diabetes Care TNDM Stock Holding History

Parametric Portfolio Associates’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$10.2M Sell
88,132
-22,271
-20% -$2.6M 0.01% 1336
2021
Q4 		$16.6M Buy
110,403
+18,567
+20% +$2.51M 0.01% 1063
2021
Q3 		$11M Buy
91,836
+39,213
+75% +$4.32M 0.01% 1287
2021
Q2 		$5.13M Buy
52,623
+18,377
+54% +$1.64M ﹤0.01% 1841
2021
Q1 		$3.02M Buy
34,246
+294
+0.9% +$27.3K ﹤0.01% 2519
2020
Q4 		$3.25M Sell
33,952
-11,179
-25% -$1.15M ﹤0.01% 2359
2020
Q3 		$5.12M Buy
45,131
+7,410
+20% +$779K ﹤0.01% 1872
2020
Q2 		$3.73M Sell
37,721
-10,450
-22% -$834K ﹤0.01% 2086
2020
Q1 		$3.1M Buy
48,171
+13,083
+37% +$917K ﹤0.01% 2095
2019
Q4 		$2.09M Sell
35,088
-19,219
-35% -$1.19M ﹤0.01% 2664
2019
Q3 		$3.2M Buy
54,307
+5,526
+11% +$353K ﹤0.01% 2343
2019
Q2 		$3.15M Sell
48,781
-6,479
-12% -$418K ﹤0.01% 2345
2019
Q1 		$3.51M Buy
55,260
+12,280
+29% +$645K ﹤0.01% 2257
2018
Q4 		$1.63M Sell
42,980
-2,171
-5% -$76.7K ﹤0.01% 2715
2018
Q3 		$1.93M Sell
45,151
-25,636
-36% -$895K ﹤0.01% 2742
2018
Q2 		$1.56M Buy
+70,787
New +$870K ﹤0.01% 2830
2015
Q4 		– Sell
-1,057
Closed -$93K – 3985
2015
Q3 		$93K Buy
+1,057
New +$123K ﹤0.01% 3199

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Parametric Portfolio Associates's TNDM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Tandem Diabetes Care (TNDM) stake by 20% in Q1 2022, selling an estimated $2.6M and leaving 88,132 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #1336.

Parametric Portfolio Associates first reported a position in TNDM in Q3 2015 and has held it in 17 quarters since. The position peaked at $16.6M in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Parametric Portfolio Associates held 88,132 shares of Tandem Diabetes Care worth $10.2M as of Q1 2022.
  • Parametric Portfolio Associates sold 22,271 Tandem Diabetes Care shares in Q1 2022, an estimated $2.6M.
  • Tandem Diabetes Care made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1336 holding.
  • Parametric Portfolio Associates first reported a position in Tandem Diabetes Care in Q3 2015 and has held it in 17 quarters since.
  • Parametric Portfolio Associates's Tandem Diabetes Care position peaked at $16.6M in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.